Ann Coloproctol Search

CLOSE


Publication ethics

  • HOME
  • EDITORIAL POLICY
  • Publication ethics

Annals of Coloproctology (ACP) adheres to the guidelines and best practices published by professional organizations, including International Committee of Medical Journal Editors (ICMJE) Recommendations (https://www.icmje.org/recommendations/) and the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by the Committee on Publication Ethics, COPE; the Directory of Open Access Journals, DOAJ; the World Association of Medical Editors, WAME; and Open Access Scholarly Publishers Association, OASPA; https://doaj.org/bestpractice). Furthermore, all processes of handling research and publication misconduct shall follow the applicable COPE flowchart (https://publicationethics.org/resources/flowcharts).

Authorship
Authorship credit should be based on (1) substantial contributions to conception and design, acquisition of data, and/or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be published, and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of it are appropriately investigated and resolved. Every author should meet all four criteria. The copyright transfer agreement and conflict of interest disclosure form must be completed and signed by the corresponding author.
  • • A list of each author’s role and ORCID should accompany the submitted paper.
  • • Correction of authorship: After the initial submission of the manuscript, any changes regarding authorship, such as adding or deleting author(s) or change in the order of authors, must be explained in a letter to the Editor from the authors concerned. The letter must include the following from the corresponding author: (1) the reason for the change of authorship and (2) a written confirmation (e-mail or letter) that all authors agree with the change in authorship. This letter must be signed by all authors of the paper. ACP does not correct authorship after publication unless a mistake has been made by the editorial staff. Changes will be done accordingly by COPE flowcharts. One of the outcomes of the COPE flowcharts is to publish a correction.
  • • Contributors: Any researcher, who does not meet all four ICMJE criteria for authorship discussed above but contribute substantively to study in terms of idea development, manuscript writing, conducting research, data analysis, and financial support should have their contributions listed in the Acknowledgments section of the article. ACP encourages authors to fully acknowledge the contribution of the patients and the public to their research when appropriate.
Originality and duplicate publication
All submitted manuscripts should be original and should not be under consideration for publication by other scientific journals at the same time. No part of an accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. If duplicate publication of any paper published in this journal is detected, the authors will be announced in the journal, their institutions will be informed, and penalties will be imposed upon the authors.
Secondary publication
Manuscripts may be republished if they satisfy the conditions for secondary publication of the ICMJE Recommendations (https://www.icmje.org/recommendations/).
Conflict-of-interest
A conflict of interest exists when an author (or the author’s iniistitution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) their actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from being negligible to having great potential for influencing judgment. Not all relationships represent true conflicts of interest. Nevertheless, the potential for a conflict of interest can exist regardless of whether an individual believes that the relationship affects their scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, and paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion (https://www.icmje.org/disclosure-of-interest/). If there are any conflicts of interest, authors should inform the Editor and disclose them in the manuscript. In particular, all sources of funding applicable to the study should be explicitly stated. Conflicts of interest may occur during the research process; however, the important point is the disclosure itself. Disclosure allows the editors, reviewers, and readers to approach the manuscript with an understanding of the situation under which the research work was performed.
Statement of human and animal rights
Clinical research should be conducted in accordance with the World Medical Association (WMA) Declaration of Helsinki: Medical Research Involving Human Subjects (https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/). Clinical studies that do not meet the Declaration of Helsinki will not be considered for publication. Any investigations involving humans and animals should also be approved by the Institutional Review Board (IRB) and the Animal Care Committee, respectively, of the institution at which the study took place. ACP will not consider any studies involving humans or animals without appropriate approval. If necessary, the Editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct. For human subjects, identifiable information, such as patients’ names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. For animal subjects, research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be maintained.
Statement of informed consent
Informed consent should be obtained, unless waived by the IRB, from patients who participated in the clinical investigations. Copies of written informed consents should be kept for studies on human subjects. Images of human subjects should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, authors should provide assurances that such alterations do not distort scientific meaning. If consent has not been obtained, it is generally not sufficient to anonymize a photograph simply by using eye bars or blurring the face of the individual concerned.
Registration of clinical trial research
Any research involving a clinical trial should be registered with the primary national clinical trial registry site, such as the Korea Clinical Research Information Service (CRiS; https://cris.nih.go.kr/), any other primary national registry site accredited by the World Health Organization (https://www.who.int/clinical-trials-registry-platform/network), or ClinicalTrials.gov (http://clinicaltrials.gov/), a service of the US National Institutes of Health.
Description of participants
Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.
Management of research and publication misconduct
Should the journal encounter suspected cases of research and publication misconduct, such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer appropriating an author’s idea or data, complaints against editors, and other issues, resolution processes will follow the applicable COPE flowchart (https://publicationethics.org/guidance/Flowcharts). Suspected cases will be discussed and decided upon by the ACP Editorial Board.
Editorial responsibilities
The Editorial Board will continuously work to monitor and safeguard publication ethics: provision of guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standards; publication of corrections, clarifications, retractions, and apologies when needed; and exclusion of plagiarism and fraudulent data. Editors have the following responsibilities: responsibility and authority to reject or accept articles; confirmation of no conflict of interest with respect to articles they reject or accept; promotion of publication of corrections or retractions when errors are found; and preservation of the reviewers’ anonymity.
  • Double-layered hand-sewn anastomosis: a valuable resource for the colorectal surgeon. Ann Coloproctol. 2022;38:271-275
  • SCImago Journal & Country Rank


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
Room 1519, Suseo Hyundai Venture-vill, 10 Bamgogae-ro 1-gil, Gangnam-gu, Seoul 06349, Korea
Tel: +82-2-2040-7737    Fax: +82-2-2040-7735    E-mail: editor@coloproctol.org                

Copyright © 2022 by Korean Society of Coloproctology.

Developed in M2PI

Close layer